LM-CD45

N/A

Report date: 2022/03/01 13:53:50

Base Information

Drug NameLM-CD45
Drug Alias NameLeucocyte modulator CD45Anti-CD45 monoclonal antibody
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionImmunosuppressantsAnti-CD45
TargetsLeukocyte common antigen
Therapy Area/IndicationsRejection of renal transplantationDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesXenovaBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXenovaBaxter International Inc
Active IndicationsN/A
Inactive IndicationsRejection of renal transplantationDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A